Tikvah Management LLC A Tyr Pharma Inc Call Options Transaction History
Tikvah Management LLC
- $318 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIFE
# of Institutions
59Shares Held
33.5MCall Options Held
7.5KPut Options Held
3.2K-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$15.9 Million0.05% of portfolio
-
Logos Global Management LP San Francisco, CA3.1MShares$4.84 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$4.14 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$2.97 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.68MShares$2.62 Million0.03% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $44.7M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...